CALCITRIOL AND 22-OXACALCITRIOL (OCT) PREVENT THE DECREASE IN VITAMIN-D-RECPETOR CONTENT IN THE PARATHYROID-GLANDS OF UREMIC RATS

被引：0
|
作者：
DENDA, M
FINCH, J
BROWN, AJ
NISHII, Y
KUBODERA, N
SLATOPOLSKY, E
机构：
[1] WASHINGTON UNIV,ST LOUIS,MO 63130
[2] CHUGAI PHARMACEUT CO LTD,TOKYO 171,JAPAN
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1995年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S277 / S277
页数：1
相关论文
共 20 条
  • [1] 1,25-dihydroxyvitamin D-3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats
    Denda, M
    Finch, J
    Brown, AJ
    Nishii, Y
    Kubodera, N
    Slatopolsky, E
    KIDNEY INTERNATIONAL, 1996, 50 (01) : 34 - 39
  • [2] METABOLISM OF 22-OXACALCITRIOL BY A VITAMIN-D-INDUCIBLE PATHWAY IN CULTURED PARATHYROID CELLS
    BROWN, AJ
    BERKOBEN, M
    RITTER, C
    KUBODERA, N
    NISHII, Y
    SLATOPOLSKY, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (02) : 759 - 764
  • [3] History of the development of new vitamin D analogs:: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)calcitriol (ED-71)
    Nishii, Y
    Okano, T
    STEROIDS, 2001, 66 (3-5) : 137 - 146
  • [4] THE NONCALCEMIC ANALOG OF VITAMIN-D, 22-OXACALCITRIOL, SUPPRESSES PARATHYROID-HORMONE SYNTHESIS AND SECRETION
    BROWN, AJ
    RITTER, CR
    FINCH, JL
    MORRISSEY, J
    MARTIN, KJ
    MURAYAMA, E
    NISHII, Y
    SLATOPOLSKY, E
    JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (03): : 728 - 732
  • [5] A NOVEL NON-CALCEMIC VITAMIN-D ANALOG 22-OXACALCITRIOL (OCT) FOR THE TREATMENT OF HYPERPARATHYROIDISM
    BROWN, A
    RITTER, C
    MORRISSEY, J
    FINCH, J
    MARTIN, K
    MURAYAMA, E
    NISHII, Y
    SLATOPOLSKY, E
    CLINICAL RESEARCH, 1989, 37 (02): : A569 - A569
  • [6] PHOSPHORUS ADAPTATION IN RATS IN ABSENCE OF VITAMIN-D OR PARATHYROID-GLANDS
    CRAMER, CF
    MCMILLAN, J
    AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 239 (04): : G261 - G265
  • [7] Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats
    Matsui, Isao
    Hamano, Takayuki
    Tomida, Kodo
    Inoue, Kazunori
    Takabatake, Yoshitsugu
    Nagasawa, Yasuyuki
    Kawada, Noritaka
    Ito, Takahito
    Kawachi, Hiroshi
    Rakugi, Hiromi
    Imai, Enyu
    Isaka, Yoshitaka
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (08) : 2354 - 2361
  • [8] The noncalcemic vitamin D analogues EB1089 and 22-oxacalcitriol interact with the vitamin D receptor and suppress parathyroid hormone-related peptide gene expression
    Falzon, M
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1997, 127 (01) : 99 - 108
  • [9] 22-OXACALCITRIOL (OCT) A NOVEL NON-CALCEMIC VITAMIN-D ANALOG SUPPRESSES PTH IN CHRONIC-RENAL-FAILURE
    BROWN, A
    LOPEZHILKER, S
    RITTER, C
    MORRISSEY, J
    FINCH, J
    MARTIN, KJ
    MURAYAMA, E
    NISHII, Y
    SLATOPOLSKY, E
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 464 - 464
  • [10] In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3
    Hirata, M
    Katsumata, K
    Endo, K
    Fulcushima, N
    Ohkawa, H
    Fukagawa, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (09) : 1770 - 1776
12